Next, we analyzed whether elevated expression of the “Mir34a/TF” targets (Fig. 8) is associated with molecular subtypes and stages of CRC, or CRC patient survival (Fig. 10A). The gene discussed is MIR34A; the disease is colorectal carcinoma.